Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Monogram Biosciences, Inc. | 100,000 | reported | 16 Jan 2009 | tx 18+1,850,000 |
| Innoviva, Inc. | 83,935 | reported | 22 May 2014 | tx 26+163,967−74,193 |
| Theravance Biopharma, Inc. | 78,010 | reported | 26 Apr 2022 | tx 15+136,886 |
| HUMAN GENOME SCIENCES INC | 16,000 | reported | 27 Apr 2006 | tx 1+16,000 |
| BIOMARIN PHARMACEUTICAL INC | 11,875 | reported | 10 Jun 2015 | tx 11+80,025 |
| Praxis Precision Medicines, Inc. | 10,520 | reported | 26 Jun 2025 | tx 6+121,636 |
| VERTEX PHARMACEUTICALS INC / MA | 4,527 | reported | 01 Jun 2020 | tx 23+149,435−100,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jun 2025 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 10,520 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 8,566 | 0.00 USD | deriv |
| 12 Jun 2023 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 28,981 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 22,753 | 0.00 USD | deriv |
| 26 Apr 2022 | GRANT_AWARD | Theravance Biopharma, Inc. | 9,852 | 0.00 USD | |
| 26 Apr 2022 | GRANT_AWARD | Theravance Biopharma, Inc. | 28,000 | 0.00 USD | deriv |
| 13 May 2021 | OTHER | Praxis Precision Medicines, Inc. | 28,473 | 0.00 USD | |
| 08 Jun 2021 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 22,343 | 0.00 USD | deriv |
| 27 Apr 2021 | GRANT_AWARD | Theravance Biopharma, Inc. | 9,828 | 0.00 USD | |
| 27 Apr 2021 | GRANT_AWARD | Theravance Biopharma, Inc. | 6,000 | 0.00 USD | deriv |
| 01 Jun 2020 | GRANT_AWARD | VERTEX PHARMACEUTICALS INC / MA | 4,527 | 0.00 USD | deriv |
| 28 Apr 2020 | GRANT_AWARD | Theravance Biopharma, Inc. | 6,635 | 0.00 USD | |
| 28 Apr 2020 | GRANT_AWARD | Theravance Biopharma, Inc. | 6,000 | 0.00 USD | deriv |
| 02 Jan 2020 | SALE | VERTEX PHARMACEUTICALS INC / MA | 10,134 | 219.37 USD | |
| 02 Jan 2020 | SALE | VERTEX PHARMACEUTICALS INC / MA | 100 | 220.08 USD | |
| 02 Jan 2020 | SALE | VERTEX PHARMACEUTICALS INC / MA | 7,266 | 218.73 USD | |
| 02 Jan 2020 | SALE | VERTEX PHARMACEUTICALS INC / MA | 2,500 | 217.72 USD | |
| 02 Jan 2020 | EXERCISE | VERTEX PHARMACEUTICALS INC / MA | 20,000 | 72.14 USD | |
| 02 Jan 2020 | EXERCISE | VERTEX PHARMACEUTICALS INC / MA | 20,000 | 0.00 USD | deriv |
| 30 Dec 2019 | EXERCISE | VERTEX PHARMACEUTICALS INC / MA | 30,000 | 65.65 USD | |
| 30 Dec 2019 | SALE | VERTEX PHARMACEUTICALS INC / MA | 500 | 220.25 USD | |
| 30 Dec 2019 | SALE | VERTEX PHARMACEUTICALS INC / MA | 300 | 221.16 USD | |
| 30 Dec 2019 | SALE | VERTEX PHARMACEUTICALS INC / MA | 7,402 | 218.05 USD | |
| 30 Dec 2019 | SALE | VERTEX PHARMACEUTICALS INC / MA | 21,798 | 218.93 USD | |
| 30 Dec 2019 | EXERCISE | VERTEX PHARMACEUTICALS INC / MA | 30,000 | 0.00 USD | deriv |